IP Library Granted Patent US 9,410,142
Granted Patent B2
US 9,410,142 · App. 13/884,420 · Granted Aug 9, 2016

Dendrimer-based excipients for the attenuation of protein aggregation

Inventors: Bernhardt L. Trout, II (Cambridge, MA); Diwakar Shukla (Stanford, CA); Curtiss P. Schneider (Melrose, MA)
Assignee: Massachusetts Institute of Technology
C12N9/96C07C279/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,410,142
App. No.
13/884,420
Granted
Aug 9, 2016
Kind
B2
Abstract

One aspect of the invention is a salt comprising guanidinium groups, as shown in formula I. Another aspect of the invention is a salt comprising guanidinium groups, as shown in formula II. Another aspect of the invention is a salt comprising guanidinium groups, as shown in formula III. Another aspect of the invention is a salt comprising guanidinium groups, as shown in formula IV. Yet another aspect of the invention is a salt comprising guanidinium groups, as shown in formula I, II, III, and IV further comprising independently for each occurrence citrate, phosphate, or sulfate anion. Also disclosed are compositions comprising a protein and a salt comprising guanidinium groups, as shown in formula I, II, III, and IV. Also provided are methods of increasing shelf life of an aqueous solution of a protein and decreasing the amount of protein aggregation in an aqueous solution of a protein.

Claims (54)

1. A salt, comprising a plurality of anions; and a cation represented by formula I:

wherein, independently for each occurrence,

each anion is

Z is —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, or —CH 2 CH 2 CH 2 CH 2 CH 2 —;

Y is —CH 2 —, —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, or —CH 2 CH 2 CH 2 CH 2 CH 2 —;

X 1 is

X 2 is

and

X 3 is

2. A salt, comprising a plurality of anions; and a cation represented by formula II:

wherein, independently for each occurrence,

each anion is

Z is —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, or —CH 2 CH 2 CH 2 CH 2 CH 2 —;

Y is —CH 2 —, —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, or —CH 2 CH 2 CH 2 CH 2 CH 2 —;

X 1 is

X 2 is

and

X 3 is

3. A salt, comprising a plurality of anions; and a cation represented by formula III:

wherein, independently for each occurrence,

each anion is

X 1 is

X 2 is

X 3 is

 and

X 4 is

4. A salt, comprising a plurality of anions; and a cation represented by formula IV:

wherein, independently for each occurrence,

each anion is

Z is —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, or —CH 2 CH 2 CH 2 CH 2 CH 2 —;

X 1 is

X 2 is

X 3 is

 and

X 4 is

5. The salt of claim 1 , wherein X 1 is

6. The salt of claim 1 , wherein X 1 is

and X 2 is

7. The salt of claim 1 , wherein X 1 is

and X 2 is

8. The salt of claim 1 , wherein Z is —CH 2 CH 2 —.

9. The salt of claim 1 , wherein Y is —CH 2 CH 2 —.

10. The salt of claim 1 , wherein Y is —CH 2 CH 2 —; and Z is —CH 2 CH 2 —.

11. The salt of claim 1 , wherein each anion is

12. The salt of claim 1 , wherein each anion is

13. The salt of claim 1 , wherein each anion is

14. A composition, comprising a protein; and a salt of claim 1 .

15. The composition of claim 14 , wherein the protein is selected from the group consisting of antibodies and enzymes.

16. A method of increasing shelf life of an aqueous solution of a protein, comprising:

combining an aqueous solution of a protein and an effective amount of a salt of claim 1 .

17. The method of claim 16 , wherein the protein is selected from the group consisting of antibodies and enzymes.

18. A method of decreasing the amount of protein aggregation in an aqueous solution of a protein, comprising:

combining an aqueous solution of a protein and an effective amount of a salt of claim 1 .

19. The method of claim 18 , wherein the protein is selected from the group consisting of antibodies and enzymes.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 10, 2013
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030584/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2013
From: TROUT, BERNHARDT L., II; SHUKLA, DIWAKAR; SCHNEIDER, CURTISS P.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 030550/0885 →
Continuity (2)
Provisional Application 61412600 · Nov 11, 2010
Related Publication 20140004592A1 · Jan 2, 2014